Latest News

Topiramate reduces heavy drinking among patients seeking to cut down on alcohol consumption

Heavy alcohol consumption is common in the United States and takes a personal and societal toll, with an annual estimated cost of 3.5 billion. Researchers have shown that the anticonvulsant medication, topiramate, previously shown to reduce drinking in patients committed to abstinence from alcohol, can also be helpful in treating problem drinkers whose aim is to curb their alcohol consumption ? particularly among a specific group of patients whose genetic makeup appears to be linked to the efficacy of the therapy.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • A strong welfare state mitigates the impact of the Great Recession

  • Costs to treat bleeding strokes increases 10 years later

  • For brain hemorrhage, risk of death lower at high-volume hospitals

  • Nursery places for three-year-olds: introduction of free entitlement did not deliver long-term benefits for children?s development, new research finds

  • Boosting use of multi-sensory environments in dementia care

  • Clot dissolver tpa's tardy twin could aid in stroke recovery

  • Exposure therapy appears helpful in treating patients with prolonged grief

  • Omega 3 can help children with ADD, experts say

  • Music therapy reduces depression in children, adolescents

  • Teens whose parents exert more psychological control have trouble with closeness, independence

  •